Novel Administration of Clofazimine for the Treatment of Infection.
Clicks: 112
ID: 108011
2020
Article Quality & Performance Metrics
Overall Quality
Improving Quality
0.0
/100
Combines engagement data with AI-assessed academic quality
Reader Engagement
Emerging Content
0.3
/100
1 views
1 readers
Trending
AI Quality Assessment
Not analyzed
Abstract
Clofazimine has demonstrated in vitro activity against many nontuberculous mycobacteria. We present the case of a woman with cystic fibrosis who developed disseminated macrolide-resistant infection following lung transplantation treated in part with clofazimine. We describe the novel administration of clofazimine via gastrostomy tube.Reference Key |
valinetz2020novelopen
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
---|---|
Authors | Valinetz, Ethan;Stankiewicz Karita, Helen;Pottinger, Paul S;Jain, Rupali; |
Journal | Open forum infectious diseases |
Year | 2020 |
DOI | 10.1093/ofid/ofaa183 |
URL | |
Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.